NASDAQ: OCGN Investor Notice: Update in Lawsuit for Investors Who Lost Money With Ocugen, Inc. Shares Announced by the Shareholders Foundation

mail@shareholdersfoundation.com

The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in Ocugen, Inc. (NASDAQ:OCGN) shares. Investors in NASDAQ: OCGN shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in Ocugen, Inc. (NASDAQ:OCGN) shares.

mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554

Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) prior to May 2020 and continue to hold any of those NASDAQ: OCGN shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On April 1, 2024, Ocugen, Inc. filed a Form with the SEC stating that in connection with the preparation of the financial statements of the Company for the year ended December 31, 2023, it identified certain accounting errors and that as a result, it intends to restate its financial statements for the year ended December 31, 2022 and for each of the first three quarters of 2022 and 2023 in the 2023 Form 10-K, the review and preparation of which is currently ongoing..

On April 11, 2024, an investor in NASDAQ: OCGN shares filed a lawsuit against Ocugen, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants made materially false and/or misleading statements and/or failed to disclose that Ocugen's financial statements from May 8, 2020 to the present were materially misstated, that Ocugen, Inc. did not have adequate internal controls, and that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

On August 6, 2024, the court appointed a lead plaintiff and lead counsel.

Those who purchased NASDAQ: OCGN shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact Information

Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554

SOURCE: Shareholders Foundation, Inc.

Source: Shareholders Foundation, Inc.

Related Media

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Shareholders Foundation, Inc.
3111 Camino del Rio N Ste 423
San Diego, CA
92108-5720

Contacts


More Press Releases